Interleukin-1 Receptor Antagonist for the Treatment of Heart Failure in Patients With Left Ventricular Assist Devices
Phase of Trial: Phase I/II
Latest Information Update: 16 May 2017
At a glance
- Drugs Anakinra (Primary)
- Indications Heart failure
- Focus Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 09 May 2017 Status changed from recruiting to completed.
- 24 Jun 2016 Planned End Date changed from 1 Dec 2015 to 1 Jan 2017.